Rodney S Markin - Net Worth and Insider Trading
Rodney S Markin Net Worth
The estimated net worth of Rodney S Markin is at least $138,528 dollars as of 2024-04-29. Rodney S Markin is the Director of Cardiff Oncology Inc and owns about 31,060 shares of Cardiff Oncology Inc (CRDF) stock worth over $138,528. Details can be seen in Rodney S Markin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Rodney S Markin has not made any transactions after 2021-03-26 and currently still holds the listed stock(s).
Transaction Summary of Rodney S Markin
Rodney S Markin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rodney S Markin owns 2 companies in total, including Cardiff Oncology Inc (CRDF) , and Precipio Inc (PRPO) .
Click here to see the complete history of Rodney S Markin’s form 4 insider trades.
Insider Ownership Summary of Rodney S Markin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2021-03-26 | director |
| PRPO | Precipio Inc | 2009-05-20 | director |
Rodney S Markin Latest Holdings Summary
Rodney S Markin currently owns a total of 1 stock. Rodney S Markin owns 31,060 shares of Cardiff Oncology Inc (CRDF) as of March 26, 2021, with a value of $138,528.
Latest Holdings of Rodney S Markin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2021-03-26 | 31,060 | 4.46 | 138,528 |
Holding Weightings of Rodney S Markin
Rodney S Markin Form 4 Trading Tracker
According to the SEC Form 4 filings, Rodney S Markin has made a total of 2 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Cardiff Oncology Inc is the acquisition of 2,900 shares on March 26, 2021, which cost Rodney S Markin around $29,928.
Insider Trading History of Rodney S Markin
- 1
Rodney S Markin Trading Performance
GuruFocus tracks the stock performance after each of Rodney S Markin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rodney S Markin is 69.16%. GuruFocus also compares Rodney S Markin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rodney S Markin within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rodney S Markin's insider trading performs compared to the benchmark.
Performance of Rodney S Markin
Average Return
80.14%
Outperforming Transactions
25%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.85 | 69.16 | 244.05 | 80.14 | -26.52 | 4.92 |
| Relative Return to S&P 500(%) | 9.23 | 59.72 | 240.02 | 61.61 | -34.11 | -8.02 |
Rodney S Markin Ownership Network
Ownership Network List of Rodney S Markin
Ownership Network Relation of Rodney S Markin
Rodney S Markin Owned Company Details
What does Cardiff Oncology Inc do?
Who are the key executives at Cardiff Oncology Inc?
Rodney S Markin is the director of Cardiff Oncology Inc. Other key executives at Cardiff Oncology Inc include Chief Medical Officer Fairooz Kabbinavar , Chief Scientific Officer Mark Erlander , and Chief Financial Officer James E. Levine .
Cardiff Oncology Inc (CRDF) Insider Trades Summary
Over the past 18 months, Rodney S Markin made no insider transaction in Cardiff Oncology Inc (CRDF). Other recent insider transactions involving Cardiff Oncology Inc (CRDF) include a net purchase of 52,950 shares made by Gary W Pace , and a net purchase of 10,000 shares made by Mark Erlander .
In summary, during the past 3 months, insiders sold 0 shares of Cardiff Oncology Inc (CRDF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiff Oncology Inc (CRDF) were sold and 62,950 shares were bought by its insiders, resulting in a net purchase of 62,950 shares.
Cardiff Oncology Inc (CRDF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiff Oncology Inc Insider Transactions
Rodney S Markin Mailing Address
Above is the net worth, insider trading, and ownership report for Rodney S Markin. You might contact Rodney S Markin via mailing address: C/o University Of Nebr Medical Center, 983135 Nebraska Medical Center, Omaha Ne 68198-3135.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
